antifungal

Basilea’s Antifungal Cresemba Sales in Latin America Trigger Milestone Payment from Partner Knight Therapeutics

(IN BRIEF) Basilea Pharmaceutica Ltd (SIX: BSLN) has announced that its partner Knight Therapeutics Inc. (TSX: GUD) exceeded the sales…

4 months ago

Sandoz acquires Mycamine, reinforcing its anti-infectives portfolio

(IN BRIEF) Sandoz, a global leader in off-patent (generic and biosimilar) medicines, has signed an agreement to acquire worldwide product…

1 year ago

Basilea to receive sales milestone payments from Astellas based on exceeding certain thresholds from the sales of antifungal Cresemba®

BASEL, 11-Dec-2018 — /EuropaWire/ — Basilea Pharmaceutica Ltd. (SIX: BSLN) announced today that the sales of the antifungal Cresemba® (isavuconazole) by Astellas…

5 years ago